Keymed Biosciences (HKSE:02162) Cash From Other Investing Activities : HK$128.4 Mil (TTM As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Keymed Biosciences Cash From Other Investing Activities?

Cash from other investing activities means the cash received by a company that comes from other investing activities.

Keymed Biosciences's cash from other investing activities for the six months ended in Dec. 2024 was HK$70.4 Mil. It means Keymed Biosciences received HK$70.4 Mil from other investing activities. Keymed Biosciences's cash from other investing activities for the trailing twelve months (TTM) ended in Dec. 2024 was HK$128.4 Mil.

Keymed Biosciences Cash From Other Investing Activities Historical Data

The historical data trend for Keymed Biosciences's Cash From Other Investing Activities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Keymed Biosciences Cash From Other Investing Activities Chart

Keymed Biosciences Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Cash From Other Investing Activities

Get a 7-Day Free Trial

13.88

8.51

233.38

164.45

127.91

Keymed Biosciences Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Cash From Other Investing Activities	Get a 7-Day Free Trial						127.80	42.15	117.79	57.97	70.42

Keymed Biosciences Cash From Other Investing Activities Calculation

Cash from other investing activities means the cash received by a company that comes from other investing activities.

Cash From Other Investing Activities for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$128.4 Mil.

Keymed Biosciences Cash From Other Investing Activities Related Terms

Thank you for viewing the detailed overview of Keymed Biosciences's Cash From Other Investing Activities provided by GuruFocus.com. Please click on the following links to see related term pages.

Keymed Biosciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Keymed Biosciences Inc (HKSE:02162) » Definitions » Cash From Other Investing Activities

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 18 BioTown Middle Road, Building D2, Tianfu International BioTown, Chengdu, Sichuan, CHN, 610219

Website

https://www.keymedbio.com

Keymed Biosciences Inc is a biotechnology company with multiple clinical-stage assets. The company is focused on the in-house discovery and development of biological therapies that address large underserved medical needs in the autoimmune and oncology therapeutic areas. Its clinical-stage drug candidates include CM310, CM326, CM313, and CM336 among others. The company is engaged in biopharmaceutical research and development, which is regarded as a single reportable segment. Geographically, it generates a majority of its revenue from overseas markets and the rest from Mainland China.

Executives

Chen Bo	2201 Interest of corporation controlled by you
Eagle Hero Management Limited	2101 Beneficial owner
Trident Trust Company (hk) Limited	2301 Trustee
Moonshot Holdings Limited	2101 Beneficial owner
Hh Kny Holdings Limited
Hillhouse Investment Management, Ltd.
Boyu Capital Group Holdings Ltd
Xyxy Holdings Ltd.
Tong Xiaomeng

Keymed Biosciences Headlines

No Headlines